Mechanisms of albuminuria in the chronic nitric oxide inhibition model

Area of Science:

• Nephrology
• Physiology
• Pharmacology

Background:

• Chronic nitric oxide (NO) inhibition is linked to hypertension and renal injury.
• Salt overload exacerbates renal damage, leading to massive albuminuria.
• Understanding the mechanisms impairing glomerular permselectivity is crucial for kidney health.

Purpose of the Study:

• To investigate how chronic nitric oxide inhibition and salt overload impair glomerular permselectivity.
• To determine the role of glomerular basement membrane (GBM) anionic sites and size selectivity in albuminuria.
• To assess the reversibility of these renal abnormalities.

Main Methods:

• Adult male Munich-Wistar rats were fed standard or high-salt diets with or without the NO inhibitor N(omega)-nitro-L-arginine methyl ester (L-NAME) for 30 days.
• Albuminuria levels were measured.
• Glomerular basement membrane (GBM) anionic site density was estimated using cationic ferritin binding.
• Fractional clearance of neutral dextran (phi) was assessed to evaluate glomerular size selectivity.

Main Results:

• L-NAME treatment with standard salt moderately increased albuminuria, decreased GBM anionic sites by ~35%, and moderately increased dextran clearance.
• L-NAME with high salt caused massive albuminuria, nearly tripled dextran clearance, and depleted GBM anionic sites.
• GBM thickening was observed in both L-NAME treated groups.
• Renal abnormalities were largely reversed after treatment cessation.

Conclusions:

• Chronic nitric oxide inhibition, especially with salt overload, impairs glomerular size and charge selectivity, leading to reversible albuminuria.
• These impairments appear to be functional disruptions of the glomerular wall rather than permanent structural damage.
• Reversibility suggests potential therapeutic targets for mitigating L-NAME-induced kidney injury.